EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy

Jintao Wang, Paul Silaghi, Daniel T Eitzman

Journal of Thrombosis and Haemostasis · 2026-07 · 24 (7) · 2593-2599

DOI: 10.1016/j.jtha.2026.03.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-07. Verfasst von Jintao Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cardiovascular Research Center, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Venous Thrombosis, Anemia, Sickle Cell, Hemoglobin, Sickle, Blood Coagulation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Michigan Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sickle cell disease (SCD) is characterized by chronic hemolytic anemia and recurrent vaso-occlusive events. Polymerization of deoxygenated sickle hemoglobin (HbS) increases erythrocyte rigidity, promoting microvascular occlusion, tissue hypoxia, and hemolysis. SCD is associated with a heightened risk of deep venous thrombosis, but the mechanisms remain unclear. OBJECTIVES: To determine the causal role of SCD in venous thrombosis and to evaluate the therapeutic potential of hemoglobin degradation by Plasmodium falciparum plasmepsin I (PMI). METHODS: Venous thrombosis was induced by femoral vein ligation in SCD and wild-type (WT) mice. Thrombus morphology was analyzed by scanning electron microscopy. Plasma-free hemoglobin levels were measured during coagulation, and the effects of recombinant PMI on free hemoglobin and thrombus formation were assessed. In addition, in vitro assays evaluated the impact of HbS on clotting time compared with normal hemoglobin. RESULTS: Thrombi developed in all SCD mice and most WT controls following ligation. Scanning electron microscopy demonstrated distinct thrombus architecture in SCD, featuring rigid, elongated erythrocytes interconnected by fibrin-like strands and frequent membrane disruption, compared with polyhedrocyte-rich WT thrombi. Plasma-free hemoglobin increased during static incubation of SCD blood and was consumed during coagulation, implicating it in clot formation. In vitro, HbS addition shortened the clotting time compared with normal hemoglobin. Treatment with PMI reduced free plasma hemoglobin and significantly decreased thrombus size in SCD mice. CONCLUSION: Sickle hemoglobin contributes to venous thrombogenesis through procoagulant activity and thrombus stabilization. Targeting free HbS with hemoglobinase therapy may represent a novel therapeutic strategy for thrombotic complications in SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThrombosisAnemia, Sickle CellHemoglobin, SickleBlood CoagulationAnimalsDisease Models, AnimalMicroscopy, Electron, ScanningMaleMice, Inbred C57BLMiceHumansErythrocytes

Stichwörter der Autor:innen

blood coagulationhemoglobinplasmepsin Isickle cell diseasevenous thrombosis

Substanzen

Hemoglobin, Sickle

Autor:innen und Institutionen

  • Department of Internal Medicine, Cardiovascular Research Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, Cardiovascular Research Center, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: deitzman@umich.edu.

Förderung

  • University of Michigan Medical School

Zitieren

APA

Wang, J., Silaghi, P., & Eitzman, D. T. (2026). Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy. Journal of Thrombosis and Haemostasis, 24(7), 2593-2599. https://doi.org/10.1016/j.jtha.2026.03.026

Vancouver

Wang J, Silaghi P, Eitzman DT. Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy. Journal of Thrombosis and Haemostasis. 2026;24(7):2593-2599. doi:10.1016/j.jtha.2026.03.026

BibTeX
@article{Wang2026,
  author = {Wang, Jintao and Silaghi, Paul and Eitzman, Daniel T},
  title = {Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {7},
  pages = {2593--2599},
  doi = {10.1016/j.jtha.2026.03.026}
}
Kostenlos starten →